Cell Signaling: Macrovascular Complications of Diabetes

细胞信号转导:糖尿病的大血管并发症

基本信息

  • 批准号:
    6834599
  • 负责人:
  • 金额:
    $ 30.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 2006-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): A majority of people with diabetes die of cardiovascular disease caused by atherosclerosis that is accelerated by diabetes. The factors that drive diabetes-accelerated atherosclerosis are still poorly understood. Our recent studies on a new porcine model show that diabetes in combination with elevated lipid intake causes increased accumulation and proliferation of arterial smooth muscle cells (SMCs) in lesions of atherosclerosis. The increased SMC proliferation occurs concomitant with hyperglycemia and elevated levels of plasma triglycerides. High glucose levels are not sufficient to induce SMC proliferation, but certain fatty acids common in triglycerides (oleate and linoleate) stimulate SMC proliferation in the presence of insulin-like growth factor I (IGF-I). We propose that diabetes leads to an increased amount of IGF-I and of lipoprotein lipase in lesion macrophages, and that lipoprotein lipase degrades triglycerides into free fatty acids that act in synergy with IGF-I to stimulate SMC proliferation. Our goal for the next five years is to address the following questions: 1. Do oleate and linoleate enhance the growth-promoting effects of IGF-I on SMCs? 2. How do oleate and linoleate synergize with the growth-promoting action of IGF-I in SMCs? 3. Does lipoprotein lipase produced by lipid loaded macrophages increase SMC proliferation by generating oleate and linoleate? 4. Does glucose or lipids associated with diabetes stimulate SMC proliferation, lipoprotein lipase and IGF-I in lesions of atherosclerosis and does lack of macrophage-derived lipoprotein lipase result in reduced SMC proliferation? We will use several animal models of diabetes-associated atherosclerosis, isolated arterial SMCs for signal transduction studies as well as a co-culture model of monocyte derived macrophages and SMCs. Increased understanding of the regulation of SMC proliferation and accumulation in diabetic lesions of atherosclerosis may provide the basis information necessary for development of highly specific drugs that can prevent lesion progression and formation of vulnerable lesions that are likely to cause the clinical symptoms of cardiovascular complications in diabetes.
描述(由申请人提供):大多数糖尿病患者死于 由动脉粥样硬化引起的心血管疾病, 糖尿病驱动糖尿病加速动脉粥样硬化的因素仍然是 不太了解。我们最近对一种新的猪模型的研究表明,糖尿病 与脂质摄入量增加相结合,导致累积增加, 动脉平滑肌细胞(SMCs)的增殖, 动脉粥样硬化SMC增殖的增加伴随着 高血糖症和血浆甘油三酯水平升高。高葡萄糖水平 不足以诱导SMC增殖,但某些常见的脂肪酸 甘油三酯(油酸酯和亚油酸酯)刺激SMC增殖, 存在胰岛素样生长因子I(IGF-I)。我们认为糖尿病 导致病变中IGF-I和脂蛋白脂酶的量增加 脂蛋白脂肪酶将甘油三酯降解为游离脂肪酸, 与IGF-I协同作用以刺激SMC增殖的酸。我们的目标 今后五年要解决的问题是:1.做油酸和 亚油酸增强IGF-I对SMC的促生长作用?2.怎么 油酸和亚油酸与IGF-I的促生长作用协同作用, SMC?3.载脂巨噬细胞产生的脂蛋白脂酶是否增加 平滑肌细胞增殖通过产生油酸和亚油酸?4.葡萄糖或脂质 与糖尿病相关的刺激SMC增殖,脂蛋白脂酶和 IGF-I在动脉粥样硬化病变中的表达及巨噬细胞源性的缺乏 脂蛋白脂酶导致SMC增殖减少?我们将使用几个 糖尿病相关动脉粥样硬化的动物模型,分离的动脉SMC 用于信号转导研究以及单核细胞的共培养模型 衍生的巨噬细胞和SMC。增加对SMC调节的了解 在糖尿病动脉粥样硬化病变中的增殖和积累可能 提供必要的基础信息,用于开发高度特异性的 可预防病变进展和易损病变形成的药物 可能导致心血管并发症的临床症状 在糖尿病中。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karin E. Bornfeldt其他文献

Lecithin:cholesterol acyltransferase binds a discontinuous binding site on adjacent apolipoprotein A-I belts in HDL
卵磷脂:胆固醇酰基转移酶结合高密度脂蛋白中相邻载脂蛋白A - I条带上的不连续结合位点
  • DOI:
    10.1016/j.jlr.2025.100786
  • 发表时间:
    2025-05-01
  • 期刊:
  • 影响因子:
    4.100
  • 作者:
    Bethany Coleman;Shimpi Bedi;John H. Hill;Jamie Morris;Kelly A. Manthei;Rachel C. Hart;Yi He;Amy S. Shah;W. Gray Jerome;Tomas Vaisar;Karin E. Bornfeldt;Hyun Song;Jere P. Segrest;Jay W. Heinecke;Stephen G. Aller;John J.G. Tesmer;W. Sean Davidson
  • 通讯作者:
    W. Sean Davidson
Effect of insulin-like growth factor I infusion on renal hypertrophy in experimental diabetes niellitus in rats
胰岛素样生长因子I输注对实验性糖尿病大鼠肾肥大的影响
  • DOI:
    10.1007/bf00401516
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    8.2
  • 作者:
    Allan Flyvbjerg;Karin E. Bornfeldt;Hans Ørskov;Hans J. Arnqvist
  • 通讯作者:
    Hans J. Arnqvist
APOA2 increases cholesterol efflux capacity to plasma HDL by displacing the C-terminus of resident APOA1
  • DOI:
    10.1016/j.jlr.2024.100686
  • 发表时间:
    2024-12-01
  • 期刊:
  • 影响因子:
  • 作者:
    Snigdha Sarkar;Jamie Morris;Youngki You;Hannah Sexmith;Scott E. Street;Stephanie M. Thibert;Isaac K. Attah;Chelsea M. Hutchinson Bunch;Irina V. Novikova;James E. Evans;Amy S. Shah;Scott M. Gordon;Jere P. Segrest;Karin E. Bornfeldt;Tomas Vaisar;Jay W. Heinecke;W. Sean Davidson;John T. Melchior
  • 通讯作者:
    John T. Melchior
Binding and biological effects of insulin, insulin analogues and insulin-like growth factors in rat aortic smooth muscle cells. Comparison of maximal growth promoting activities
胰岛素、胰岛素类似物和胰岛素样生长因子在大鼠主动脉平滑肌细胞中的结合和生物效应。
  • DOI:
  • 发表时间:
    1991
  • 期刊:
  • 影响因子:
    8.2
  • 作者:
    Karin E. Bornfeldt;R. A. Gidlöf;Å. Wasteson;M. Lake;A. Skottner;Hans J Arnqvist
  • 通讯作者:
    Hans J Arnqvist
Apolipoprotein C3 induces inflammasome activation only in its delipidated form
载脂蛋白 C3 仅在其去脂形式下诱导炎性小体激活
  • DOI:
    10.1038/s41590-023-01423-2
  • 发表时间:
    2023-02-13
  • 期刊:
  • 影响因子:
    27.600
  • 作者:
    Cheng-Chieh Hsu;Baohai Shao;Jenny E. Kanter;Yi He;Tomas Vaisar;Joseph L. Witztum;Janet Snell-Bergeon;Gregory McInnes;Shannon Bruse;Omri Gottesman;Adam E. Mullick;Karin E. Bornfeldt
  • 通讯作者:
    Karin E. Bornfeldt

Karin E. Bornfeldt的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karin E. Bornfeldt', 18)}}的其他基金

Triglycerides, Diabetes and Cardiovascular Disease
甘油三酯、糖尿病和心血管疾病
  • 批准号:
    10450856
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10450858
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Identifying new strategies for prevention of cardiovascular complications of diabetes
确定预防糖尿病心血管并发症的新策略
  • 批准号:
    10591588
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Identifying new strategies for prevention of cardiovascular complications of diabetes
确定预防糖尿病心血管并发症的新策略
  • 批准号:
    10395427
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis
项目1. 糖尿病、富含甘油三酯的脂蛋白和晚期动脉粥样硬化
  • 批准号:
    10450861
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10642740
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Triglycerides, Diabetes and Cardiovascular Disease
甘油三酯、糖尿病和心血管疾病
  • 批准号:
    10642739
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Identifying new strategies for prevention of cardiovascular complications of diabetes
确定预防糖尿病心血管并发症的新策略
  • 批准号:
    9893203
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Project 1. Diabetes, triglyceride-rich lipoproteins, and advanced atherosclerosis
项目1. 糖尿病、富含甘油三酯的脂蛋白和晚期动脉粥样硬化
  • 批准号:
    10642745
  • 财政年份:
    2020
  • 资助金额:
    $ 30.32万
  • 项目类别:
Structural basis for cardioprotective HDL
心脏保护性 HDL 的结构基础
  • 批准号:
    10308003
  • 财政年份:
    2019
  • 资助金额:
    $ 30.32万
  • 项目类别:

相似海外基金

EFR3: Novel gatekeeper of cell proliferation
EFR3:细胞增殖的新型看门人
  • 批准号:
    DP240102729
  • 财政年份:
    2024
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Discovery Projects
Modulation of cell proliferation by the tumor suppressor protein NRK
肿瘤抑制蛋白 NRK 对细胞增殖的调节
  • 批准号:
    23K08817
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MR imaging for the cell proliferation using in vivo click chemistry
使用体内点击化学进行细胞增殖的 MR 成像
  • 批准号:
    23K18279
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Project 1: Determine the mechanisms Cyclin D-Cdk4/6 uses to drive cell proliferation
项目 1:确定 Cyclin D-Cdk4/6 驱动细胞增殖的机制
  • 批准号:
    10867552
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
Identification of active components of sillkworm serum exhibiting cell proliferation and elucidation of the mechanism
蚕血清中细胞增殖活性成分的鉴定及其机制的阐明
  • 批准号:
    23KJ1691
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
The Role of Arginine Transport on Pancreatic Alpha Cell Proliferation and Function
精氨酸转运对胰腺α细胞增殖和功能的作用
  • 批准号:
    10678248
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
Regulation of Adherent Cell Proliferation by Matrix Viscoelasticity
基质粘弹性对贴壁细胞增殖的调节
  • 批准号:
    10735701
  • 财政年份:
    2023
  • 资助金额:
    $ 30.32万
  • 项目类别:
mRNA selective translational control required for B cell proliferation
B 细胞增殖所需的 mRNA 选择性翻译控制
  • 批准号:
    2757728
  • 财政年份:
    2022
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Studentship
mechanism of cancer cell proliferation in bone microenvironment of renal cell carcinoma
肾细胞癌骨微环境中癌细胞增殖机制
  • 批准号:
    22K09370
  • 财政年份:
    2022
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Decline of tissue stem cell proliferation and differentiation ability by chronic renal failure and preventive effects by omega-3 polyunsaturated fatty acid
慢性肾功能衰竭引起的组织干细胞增殖和分化能力下降及omega-3多不饱和脂肪酸的预防作用
  • 批准号:
    22K05529
  • 财政年份:
    2022
  • 资助金额:
    $ 30.32万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了